MALAT1 and gastric cancer: More importantly, we found that the protection against both oxaliplatin‐ and cisplatin‐induced cell apoptosis and the increases in IC50 of gastric cancer cells to oxaliplatin and cisplatin by M2‐EX were reduced by MALAT1 knockdown (Figure 3H,I; Figures S4C, S5A,B, Supporting Information).